| Authors: |
Goretti Riça I; From the Departments of Biological Engineering and Biology (I.G.R., B.A.J., T.R.E., M.B.Y.), Massachusetts Institute of Technology, Cambridge, Massachusetts; Koch Institute for Integrative Cancer Research (I.G.R., B.A.J., T.R.E., M.B.Y.), Massachusetts Institute of Technology, Cambridge, Massachusetts; Center for Precision Cancer Medicine (I.G.R., B.A.J., T.R.E., M.B.Y.), Massachusetts Institute of Technology, Cambridge, Massachusetts; Surgical Oncology Program (M.E.T., J.M.H., M.B.Y.), National Cancer Institute, National Institutes of Health, Bethesda, Maryland; Department of Surgery (A.M.G., L.A.C., J.A.L.), Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; Department of Anesthesia, Critical Care, and Pain Medicine (V.M.B.-G., S.C.R.), Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts; Department of Medicine (B.H.S.), Roswell Park Comprehensive Cancer Center, University of Buffalo School of Medicine, Buffalo, New York; and Department of Surgery (L.E.O., C.J.H., M.B.Y.), Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts., Joughin BA, Teke ME, Emmons TR, Griffith AM, Cahill LA, Banner-Goodspeed VM, Robson SC, Hernandez JM, Segal BH, Otterbein LE, Hauser CJ, Lederer JA, Yaffe MB |
